These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31819372)

  • 1. Transformation of Meloxicam Containing Nanosuspension into Surfactant-Free Solid Compositions to Increase the Product Stability and Drug Bioavailability for Rapid Analgesia.
    Bartos C; Ambrus R; Katona G; Sovány T; Gáspár R; Márki Á; Ducza E; Ivanov A; Tömösi F; Janáky T; Szabó-Révész P
    Drug Des Devel Ther; 2019; 13():4007-4020. PubMed ID: 31819372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a combined wet milling process in order to produce poly(vinyl alcohol) stabilized nanosuspension.
    Bartos C; Jójárt-Laczkovich O; Katona G; Budai-Szűcs M; Ambrus R; Bocsik A; Gróf I; Deli MA; Szabó-Révész P
    Drug Des Devel Ther; 2018; 12():1567-1580. PubMed ID: 29910603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam.
    Bartos C; Szabó-Révész P; Bartos C; Katona G; Jójárt-Laczkovich O; Ambrus R
    Molecules; 2016 Apr; 21(4):507. PubMed ID: 27110752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ginkgolides-loaded soybean phospholipid-stabilized nanosuspension with improved storage stability and in vivo bioavailability.
    Wang P; Cao X; Chu Y; Wang P
    Colloids Surf B Biointerfaces; 2019 Sep; 181():910-917. PubMed ID: 31382340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meloxicam Carrier Systems Having Enhanced Release and Aqueous Wettability Prepared Using Micro-suspensions in Different Liquid Media.
    Marinko N; Zámostný P
    AAPS PharmSciTech; 2020 May; 21(5):155. PubMed ID: 32449139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
    Sawant KK; Patel MH; Patel K
    Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle engineering/different film approaches for earlier absorption of meloxicam.
    Farid M; El-Setouhy DA; El-Nabarawi MA; El-Bayomi T
    Drug Deliv; 2016 Sep; 23(7):2309-2317. PubMed ID: 25431841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Evaluation of Meloxicam Nanocrystals by Oral Administration with Different Particle Sizes.
    Yu Y; Tian Y; Zhang H; Jia Q; Chen X; Kang D; Du Y; Song S; Zheng A
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of sodium hyaluronate-based intranasal formulations containing micro- or nanosized meloxicam particles.
    Bartos C; Ambrus R; Sipos P; Budai-Szűcs M; Csányi E; Gáspár R; Márki Á; Seres AB; Sztojkov-Ivanov A; Horváth T; Szabó-Révész P
    Int J Pharm; 2015 Aug; 491(1-2):198-207. PubMed ID: 26142244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.
    Iurian S; Bogdan C; Tomuță I; Szabó-Révész P; Chvatal A; Leucuța SE; Moldovan M; Ambrus R
    Eur J Pharm Sci; 2017 Jun; 104():356-365. PubMed ID: 28435075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel celecoxib-loaded nanosuspension using a wet media milling process.
    Jeong SC; Kim DS; Jin SG; Youn YS; Oh KT; Li DX; Yong CS; Oh Kim J; Kim KS; Choi HG
    Pharmazie; 2018 Sep; 73(9):498-502. PubMed ID: 30223931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY; Shah DA; Dave RH
    Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, Characterization and In Vivo Assessment of Repaglinide Nanosuspension for Oral Bioavailability Improvement.
    Zawar LR; Bari SB
    Recent Pat Drug Deliv Formul; 2018; 12(3):162-169. PubMed ID: 30003863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors.
    Ochi M; Kawachi T; Toita E; Hashimoto I; Yuminoki K; Onoue S; Hashimoto N
    Int J Pharm; 2014 Oct; 474(1-2):151-6. PubMed ID: 25138254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanosizing of a poorly soluble drug: technique optimization, factorial analysis, and pharmacokinetic study in healthy human volunteers.
    Elsayed I; Abdelbary AA; Elshafeey AH
    Int J Nanomedicine; 2014; 9():2943-53. PubMed ID: 24971006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication of surfactant-stabilized nanosuspension of naringenin to surpass its poor physiochemical properties and low oral bioavailability.
    Singh MK; Pooja D; Ravuri HG; Gunukula A; Kulhari H; Sistla R
    Phytomedicine; 2018 Feb; 40():48-54. PubMed ID: 29496174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meloxicam affects the inflammatory responses of bovine mammary epithelial cells.
    Caldeira MO; Bruckmaier RM; Wellnitz O
    J Dairy Sci; 2019 Nov; 102(11):10277-10290. PubMed ID: 31447141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal delivery of nanosuspension-based mucoadhesive formulation with improved bioavailability of loratadine: Preparation, characterization, and in vivo evaluation.
    Alshweiat A; Csóka I; Tömösi F; Janáky T; Kovács A; Gáspár R; Sztojkov-Ivanov A; Ducza E; Márki Á; Szabó-Révész P; Ambrus R
    Int J Pharm; 2020 Apr; 579():119166. PubMed ID: 32084574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.